Journal of Epigenetics

Journal of Epigenetics

Chrysin Modulates Cell Cycle Progression, Apoptosis, and Angiogenic Signaling in HPV16-Positive CaSki Cervical Cancer Cells

Document Type : Original Article

Authors
Department of Biology, Ra.C., Islamic Azad University, Rasht, Iran.
10.22111/jep.2026.55611.1108
Abstract
Background: Cervical cancer remains a major global health issue, mainly caused by persistent high-risk HPV infection, especially HPV16. Key molecular events include abnormal cell-cycle progression, evasion of apoptosis, and increased angiogenesis, which drive cancer progression and resistance. Naturally occurring flavonoids show promise as multi-target anticancer agents by affecting various oncogenic pathways. This study examined the cytotoxic, apoptotic, and transcriptional effects of chrysin (5,7-dihydroxyflavone) in HPV16-positive CaSki cervical cancer cells.
Methods: Cell viability was evaluated using an MTT assay after 48 h of chrysin treatment, and the half-maximal inhibitory concentration (IC₅₀) was determined. Apoptosis induction was quantified by Annexin V/PI flow cytometry, and the mRNA expression levels of Cyclin D1, Survivin, and VEGF were analyzed by quantitative real-time PCR (qRT-PCR).
Results: Chrysin significantly reduced CaSki cell viability in a dose-dependent manner, with an IC₅₀ of 112 µg/ml at 48 h. Flow cytometric analysis revealed a statistically significant increase in early and late apoptotic cell populations after chrysin exposure compared with untreated controls. At the molecular level, chrysin treatment significantly downregulated Cyclin D1 mRNA (~45% reduction; P < 0.05), indicating inhibition of the G1/S cell-cycle transition. In parallel, expression of the anti-apoptotic gene Survivin was markedly decreased (P < 0.001), consistent with enhanced apoptotic signaling. Furthermore, VEGF expression was significantly suppressed (P < 0.05), suggesting attenuation of angiogenesis-associated pathways.
Conclusions: Collectively, these findings demonstrate that chrysin exerts a coordinated, multi-target anticancer effect in HPV16-positive cervical cancer cells by suppressing proliferation, promoting apoptosis, and inhibiting angiogenic signaling, supporting its potential as a complementary therapeutic candidate for cervical cancer management.
Keywords
Subjects


Articles in Press, Accepted Manuscript
Available Online from 14 November 2026

  • Receive Date 01 June 2026
  • Revise Date 04 October 2026
  • Accept Date 14 November 2026